companydata.dkcompanydata.dk

Draupnir Bio ApS: Financial statements 2024

CVR: 38546880

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

Draupnir Bio ApS (CVR 38546880) has filed annual accounts for 2024. Equity in the 2024 report amounted to DKK 27,633,000. The solvency ratio was 78.9%. The company had 8 employees in the financial year.

Equity
DKK 27,633,000
Total Assets
DKK 35,033,000
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024---27.6 mio.8
2023---41.2 mio.29.4 mio.10
2022---39.9 mio.18.6 mio.13
2021---67 mio.53.5 mio.-
2020---60.6 mio.54.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Novo Holdings A/S registered as owner of Draupnir Bio ApSJul 10, 2024

As of July 10, 2024, Novo Holdings A/S is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.

Registered as owner of Draupnir Bio ApSJul 10, 2024

As of July 10, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 20%.

Danmarks Eksport- og Investeringsfond registered as owner of Draupnir Bio ApSJul 10, 2024

As of July 10, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.

Draupnir Bio ApS: The 2023 annual report is outMay 15, 2024

Draupnir Bio ApS has published its annual report for 2023. The net result was DKK -41,166,000.

Registered as owner of Draupnir Bio ApSMar 26, 2024

As of March 26, 2024, is registered as an owner of Draupnir Bio ApS with an ownership share of 10%.

About Draupnir Bio ApS

Draupnir Bio ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andrew Thomas Hotchkiss. The board consists of Eva-Lotta Coulter (chair), Emmanuelle Coutanceau, Ivan Burkov and Robert Andrew Donald Scott. The company's owners include Novo Holdings A/S, Coöperatieve Gilde Healthcare IV U.A. and Danmarks Eksport- og Investeringsfond. According to the 2025 annual report, the company had an average of 9 employees. Equity in the 2025 report amounted to DKK 15,256,000.

Source: annual report 2025, Danish Business Authority

Other financial years